Hemosphere - About the company
Hemosphere is an acquired company based in Eden Prairie (United States), founded in 1987. It operates as a Global healthcare company innovating and delivering medical solutions for patient care. Hemosphere has raised $9.3M in funding from Kaiser Permanente Ventures. The company has 122 active competitors, including 45 funded and 28 that have exited. Its top competitors include companies like TISSIUM, Vivasure Medical and Laminate Medical.
Company Details
Global healthcare company innovating and delivering medical solutions for patient care. It focuses on developing, manufacturing, and distributing proprietary disposable medical devices. These devices are crucial in interventional, diagnostic, and therapeutic procedures across various medical fields, including cardiology, radiology, oncology, critical care, and endoscopy. The company provides procedural solutions and a wide array of products, including catheters, guide wires, inflation devices, and custom angiography kits. It serves hospitals worldwide, offering customer support, education, and resources such as brochures, IFUs, and on-demand courses. The business model is B2B, supplying medical equipment to healthcare providers. The company is committed to corporate sustainability and innovation in the medical device industry.
Key Metrics
Founded Year
1987
Location
Eden Prairie, United States
Stage
Acquired
Total Funding
$9.3M in 1 round
Latest Funding Round
Investors
Ranked
30th among 122 active competitors
Employee Count
3,493 as on May 31, 2026
Exit Details
Acquired by CryoLife (May 15, 2012)
Legal entities associated with Hemosphere
Hemosphere is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Hemosphere, Inc CIN: 911935286 , United States, Active | Dec 31, 1986 | - | - | - |
Hemosphere's acquisition details
Click here to take a look at Hemosphere's acquisition in detail
Sign up to download Hemosphere's company profile
Hemosphere's funding and investors
Hemosphere has raised a total funding of $9.3M over 1 round. Its latest funding round was a Series A round on Mar 31, 2010 for $*****. 7 investors participated in its latest round. Hemosphere has 9 institutional investors.
Here is the list of recent funding rounds of Hemosphere:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Mar 31, 2010 | 3891018 | Series A | 8678439 | 6733467 | 1567831 | 4981159 |
Access funding benchmarks and valuations. Sign up today!View details of Hemosphere's funding rounds and investors
Hemosphere's founders and board of directors
Founder? Claim ProfileHemosphere's employee count trend
Hemosphere has 3,493 employees as of May 26. Here is Hemosphere's employee count trend over the years:
Uncover Hemosphere's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Hemosphere's Competitors and alternates
Top competitors of Hemosphere include TISSIUM, Vivasure Medical and Laminate Medical. Here is the list of Top 10 competitors of Hemosphere, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Developer of vascular sealant for open vascular surgery | $190M | 66/100 | ||
2nd |  Vivasure Medical 2009, Galway (Ireland), Acquired | Developer of polymer implants and delivery systems | $92.1M | 61/100 | |
3rd | Laminate Medical 2012, Rehovot (Israel), Series C | Device to prevent AV Fistula failure by promoting their maturation and patency | $20M | 52/100 | |
4th | EKOS Corporation 1995, Bothell (United States), Acquired | Developer of a device for thrombolysis to treat pulmonary embolism | $58.8M | 52/100 | |
5th | ivWatch 2010, Williamsburg (United States), Series E | Detecting Intravenous infiltration | $90.1M | 51/100 | |
6th | AccessClosure 2002, Mountain View (United States), Acquired | Vascular closure device | $18.7M | 50/100 | |
7th | Access Vascular 2015, Bedford (United States), Series C | Developer of hydrogel-based devices to improve venous access | $54.3M | 50/100 | |
8th | Semprus BioSciences 2006, Cambridge (United States), Acquired | Provider of bio-functional medical surfaces to interface between the body and implantable devices | $26M | 50/100 | |
9th | Cardival Medical 2002, Santa Clara (United States), Acquired | Developer of a device for vascular access management | $169M | 49/100 | |
10th |  Vantis Vascular 2022, San Jose (United States), Series C | Provider of a medical device for vascular interventions | $30M | 48/100 | |
30th | Hemosphere 1987, Eden Prairie (United States), Acquired | Global healthcare company innovating and delivering medical solutions for patient care | $9.3M | 37/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Hemosphere's competitors? Click here to see the top ones
Hemosphere's Investments and acquisitions
Hemosphere has made no investments or acquisitions yet.
Reports related to Hemosphere
Here is the latest report on Hemosphere's sector:
News related to Hemosphere
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Hemosphere
Explore our recently published companies
- Captain - Montreal based, 2021 founded, Unfunded company
- Navigo - Delhi based, 2024 founded, Unfunded company
- Skynext - Mumbai based, 2020 founded, Unfunded company
- Digital Maker - Peterhead based, 2017 founded, Unfunded company
- Byteport - San Francisco based, 1999 founded, Seed company
- Back Benchers - India based, 2024 founded, Unfunded company
